Better MedSpa review
Better MedSpa is a Chicago-based, statewide-Illinois med spa and telehealth practice under medical director Dr. Brett Brechner, DO, offering semaglutide and tirzepatide with an in-person location in Lincoln Park, Chicago.
- Semaglutide
- $300/mo (compounded)
- Tirzepatide
- $400/mo (compounded)
- Coverage
- 1 state
- Brand-name
- Compounded only
Semaglutide · modeled / year
$3,600
Tirzepatide · modeled / year
$4,800
Pricing verified August 2026
The Index scorecard
Better MedSpa scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Named medical director, Dr. Brett Brechner, DO, publicly credited on-site
- Real dollar pricing published on the memberships page for both semaglutide and tirzepatide, broken out by 1-month vs. 3-month commitment
- Serves Illinois statewide via telehealth with an in-person Lincoln Park, Chicago location
- Financing/payment plans available in addition to cash pay
The tradeoffs
- The treatment page's advertised 'Starting at $290' is the 3-month PREPAID rate, not the standing price -- month-to-month semaglutide is actually $300/month
- No pharmacy name, LegitScript certification, or lab/COA testing disclosure found anywhere on the site
- Illinois only -- not a multi-state or nationwide telehealth operation
- General aesthetic membership tiers (Silver through Concierge Circle, $150-$1,000/month) are marketed on the same page as the GLP-1 pricing in a way that could be mistaken for a requirement
The bottom line
Best for: Shoppers who want an in-person Chicago/Illinois med spa GLP-1 program and are comparing the real month-to-month rate, not the quarterly-discounted headline. Better MedSpa is a Chicago-based, statewide-Illinois med spa and telehealth practice under medical director Dr. Brett Brechner, DO, offering semaglutide and tirzepatide with an in-person location in Lincoln Park, Chicago.
Ranked #456 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Better MedSpa.
- #460Liberty— Liberty Weight Loss is a small, NJ-based GLP-1 telehealth operator offering compounded semaglutide at $247 with no published tirzepatide price.46/100
- #461SynergenX Health— SynergenX is primarily a 64-location, 10-state in-person TRT (testosterone) and HRT clinic chain, not a GLP-1-first telehealth company.46/100
- #462Superior Remedies— Superior Remedies runs three named programs — semaglutide, tirzepatide, and a dedicated GLP-1 Microdose protocol for longevity and body composition — and publishes no price for any of them.46/100
- #463Framework— Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection and a named pharmacy partner.45/100
- #464Fridays— Fridays prices compounded semaglutide from $150/mo and tirzepatide from $240/mo, but both figures require a full annual prepay.45/100
- #465LaSara Medical Group— LaSara Medical Group is a hybrid national-telehealth-plus-Southern-California-in-person provider selling compounded semaglutide (from $299/mo month-to-month, down to $233/mo equivalent on a $2,795 12-month prepay) and tirzepatide (from $399/mo, down to $325/mo equivalent on a $3,895 12-month prepay).45/100
The 18 programs nearest this one
- #457 Chronos Body Health & Wellness46
- #458 Florida Weight Loss MD46
- #459 Genesis Lifestyle Medicine46
- #466 Maven Clinic45
- #467 Roboclinic45
- #468 Steady State Health45
- #469 WeightlessRx45
- #470 HumeCare+42
- #471 9amHealth44
- #472 eMed44
- #473 FlyteHealth44
- #474 FuturHealth44
- #475 Garcia Weight Loss, Aesthetics & Hormone Therapy44
- #476 Ilant Health44
- #477 Kova44
- #478 MD Trim Clinic44
- #479 MEDVidi44
- #480 Meto44
Pricing, states and verification reflect Better MedSpa's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Better MedSpa's site. Not medical advice; see our disclosure.